Evidence map›Paper›PMID 27402952›Full record

ArticleThe Journal of cell biology2016

Cortactin promotes exosome secretion by controlling branched actin dynamics.

Seema Sinha, Daisuke Hoshino, Nan Hyung Hong, Kellye C Kirkbride, Nathan E Grega-Larson, Motoharu Seiki, Matthew J Tyska, Alissa M Weaver

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 198 papers.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 319 citations in OpenAlex.

  1. Article
  2. Article
  3. Rab27: Molecular switch of tumor exosome secretion (Review).International journal of molecular medicine · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Seema SinhaDepartment of Cancer Biology, Vanderbilt University Medical School, Nashville, TN 37232.
Daisuke HoshinoKanagawa Cancer Center, Yokohama 241-0815, Japan.
Nan Hyung HongDepartment of Cancer Biology, Vanderbilt University Medical School, Nashville, TN 37232.
Kellye C KirkbrideDepartment of Cancer Biology, Vanderbilt University Medical School, Nashville, TN 37232.ORCID 0000-0002-1853-0902
Nathan E Grega-LarsonDepartment of Cell and Developmental Biology, Vanderbilt University Medical School, Nashville, TN 37232.ORCID 0000-0002-3110-8466
Motoharu SeikiDivision of Cancer Cell Research, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Matthew J TyskaDepartment of Cell and Developmental Biology, Vanderbilt University Medical School, Nashville, TN 37232.
Alissa M WeaverDepartment of Cancer Biology, Vanderbilt University Medical School, Nashville, TN 37232 Department of Cell and Developmental Biology, Vanderbilt University Medical School, Nashville, TN 37232 Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232 alissa.weaver@vanderbilt.edu.ORCID 0000-0002-4096-8636
Vanderbilt University · USKanagawa Prefectural Hospital Organization · JPThe University of Tokyo · JP

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Molecular basis of brush border assemblyR01DK095811 · NIDDK · VANDERBILT UNIVERSITY · PI MATTHEW J TYSKA · 2013 to 2026
$4.9M
Regulation of Brush Border Structure by Myosin-1aR01DK075555 · NIDDK · VANDERBILT UNIVERSITY · PI TYSKA, MATTHEW J · 2007 to 2016
$2.7M
Exocytic pathways in HNSCC progressionR01CA163592 · NCI · VANDERBILT UNIVERSITY · PI WEAVER, ALISSA M · 2012 to 2016
$1.6M
NCATS NIH HHS UL1 TR000445NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA163592NCRR NIH HHS UL1 RR024975NEI NIH HHS P30 EY008126NICHD NIH HHS P30 HD015052NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK075555NIDDK NIH HHS R01 DK095811NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Exosomes are extracellular vesicles that influence cellular behavior and enhance cancer aggressiveness by carrying bioactive molecules. The mechanisms that regulate exosome secretion are poorly understood. Here, we show that the actin cytoskeletal regulatory protein cortactin promotes exosome secretion. Knockdown or overexpression of cortactin in cancer cells leads to a respective decrease or increase in exosome secretion, without altering exosome cargo content. Live-cell imaging revealed that cortactin controls both trafficking and plasma membrane docking of multivesicular late endosomes (MVEs). Regulation of exosome secretion by cortactin requires binding to the branched actin nucleating Arp2/3 complex and to actin filaments. Furthermore, cortactin, Rab27a, and coronin 1b coordinately control stability of cortical actin MVE docking sites and exosome secretion. Functionally, the addition of purified exosomes to cortactin-knockdown cells rescued defects of those cells in serum-independent growth and invasion. These data suggest a model in which cortactin promotes exosome secretion by stabilizing cortical actin-rich MVE docking sites.

Indexed as

Actin-Related Protein 2-3 ComplexActinsBiological TransportCell Line, TumorCell MembraneCortactinExosomesHumansMicrofilament ProteinsModels, BiologicalMolecular Docking SimulationMultivesicular BodiesPhenotypeProtein BindingPseudopodiarab GTP-Binding ProteinsActin-Related Protein 2-3 ComplexActinscoronin proteinsCortactinCTTN protein, humanMicrofilament Proteinsrab GTP-Binding ProteinsRNA, Small InterferingTetraspanin 30

Identifiers

PMID27402952
PMCPMC4949450
OpenAlexW2469270620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.